Endymed Management

Management criteria checks 3/4

Endymed's CEO is Yossi Bar-On, appointed in Mar 2017, has a tenure of 7.83 years. total yearly compensation is $287.00K, comprised of 99.3% salary and 0.7% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth ₪231.47K. The average tenure of the management team and the board of directors is 5.3 years and 2.6 years respectively.

Key information

Yossi Bar-On

Chief executive officer

US$287.0k

Total compensation

CEO salary percentage99.3%
CEO tenure7.8yrs
CEO ownership0.5%
Management average tenure5.3yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Nov 07
Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Sep 23
Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Aug 06
Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

May 24
Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Mar 11
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

Oct 23
Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jul 17
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Apr 03
Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

Nov 18
Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jun 03
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Feb 13
Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Nov 28
Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Oct 31
Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Aug 29
Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

Aug 01
Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Apr 11
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 15
Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Jan 10
Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Dec 14
Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

CEO Compensation Analysis

How has Yossi Bar-On's remuneration changed compared to Endymed's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

-US$835k

Mar 31 2024n/an/a

-US$437k

Dec 31 2023US$287kUS$285k

US$553k

Sep 30 2023n/an/a

US$773k

Jun 30 2023n/an/a

US$998k

Mar 31 2023n/an/a

US$907k

Dec 31 2022US$328kUS$316k

US$850k

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$434kUS$321k

US$5m

Sep 30 2021n/an/a

US$2m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$838k

Dec 31 2020US$268kUS$266k

US$308k

Compensation vs Market: Yossi's total compensation ($USD287.00K) is below average for companies of similar size in the IL market ($USD413.52K).

Compensation vs Earnings: Yossi's compensation has been consistent with company performance over the past year.


CEO

Yossi Bar-On (56 yo)

7.8yrs

Tenure

US$287,000

Compensation

Mr. Yossi Bar-On, CPA has been the Chief Executive Officer of Endymed Ltd. since March 22, 2017. Mr. Bar-On served as the Chief Financial Officer since July 2014 and Chief Operating Officer at Sanara Ventu...


Leadership Team

NamePositionTenureCompensationOwnership
Yossi Bar-On
Chief Executive Officer7.8yrsUS$287.00k0.53%
₪ 231.5k
Rami Aviram
Chief Financial Officer6.5yrsUS$204.00kno data
Amir Ganun
Vice President of International Sales & Marketing4.5yrsUS$279.00kno data
Bill Scott
President of Endymed Inc.2.8yrsUS$352.00kno data
Sima Weissman
Vice President of Research & Development6.2yrsUS$144.00kno data
Asaf Nachmanovich
Chief Operating Officer2yrsno datano data

5.3yrs

Average Tenure

53yo

Average Age

Experienced Management: ENDY's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gilai Dolev
Independent External Director2.5yrsno datano data
Ofer Zvi
Director7yrsno datano data
Tal Rubinstein
Independent External Director2.6yrsno datano data
Ariel Rubashkin
Independent Director4yrsno datano data
Xiu Yang
Director2.2yrsno datano data

2.6yrs

Average Tenure

50yo

Average Age

Experienced Board: ENDY's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 05:51
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Endymed Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution